Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin
- PMID: 17355872
- DOI: 10.1016/j.str.2007.02.002
Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin
Abstract
Sirtuins are NAD(+)-dependent protein deacetylases and are emerging as molecular targets for the development of pharmaceuticals to treat human metabolic and neurological diseases and cancer. To date, several sirtuin inhibitors and activators have been identified, but the structural mechanisms of how these compounds modulate sirtuin activity have not yet been determined. We identified suramin as a compound that binds to human SIRT5 and showed that it inhibits SIRT5 NAD(+)-dependent deacetylase activity with an IC(50) value of 22 microM. To provide insights into how sirtuin function is altered by inhibitors, we determined two crystal structures of SIRT5, one in complex with ADP-ribose, the other bound to suramin. Our structural studies provide a view of a synthetic inhibitory compound in a sirtuin active site revealing that suramin binds into the NAD(+), the product, and the substrate-binding site. Finally, our structures may enable the rational design of more potent inhibitors.
Similar articles
-
Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).ChemMedChem. 2007 Oct;2(10):1419-31. doi: 10.1002/cmdc.200700003. ChemMedChem. 2007. PMID: 17628866
-
Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.Biochemistry. 2004 Aug 3;43(30):9877-87. doi: 10.1021/bi049592e. Biochemistry. 2004. PMID: 15274642
-
Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.Biochim Biophys Acta. 2010 Aug;1804(8):1658-65. doi: 10.1016/j.bbapap.2009.09.011. Epub 2009 Sep 18. Biochim Biophys Acta. 2010. PMID: 19766741 Review.
-
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.J Med Chem. 2006 Dec 14;49(25):7307-16. doi: 10.1021/jm060118b. J Med Chem. 2006. PMID: 17149860
-
Inhibitors of NAD+ dependent histone deacetylases (sirtuins).Curr Pharm Des. 2008;14(6):562-73. doi: 10.2174/138161208783885380. Curr Pharm Des. 2008. PMID: 18336301 Review.
Cited by
-
Mitochondrial sirtuins: Energy dynamics and cancer metabolism.Mol Cells. 2024 Feb;47(2):100029. doi: 10.1016/j.mocell.2024.100029. Epub 2024 Feb 6. Mol Cells. 2024. PMID: 38331199 Free PMC article. Review.
-
SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity.J Biol Chem. 2012 Jan 20;287(4):2468-76. doi: 10.1074/jbc.M111.285031. Epub 2011 Dec 7. J Biol Chem. 2012. PMID: 22157016 Free PMC article.
-
Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.Cancer Res. 2016 May 1;76(9):2500-6. doi: 10.1158/0008-5472.CAN-15-2733. Epub 2016 Apr 20. Cancer Res. 2016. PMID: 27197261 Free PMC article. Review.
-
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C521-C545. doi: 10.1152/ajpcell.00451.2021. Epub 2022 Feb 9. Am J Physiol Cell Physiol. 2022. PMID: 35138178 Free PMC article. Review.
-
Sirtuin activators and inhibitors: Promises, achievements, and challenges.Pharmacol Ther. 2018 Aug;188:140-154. doi: 10.1016/j.pharmthera.2018.03.004. Epub 2018 Mar 22. Pharmacol Ther. 2018. PMID: 29577959 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases